Research & Innovation

Focus area of Research

Waksman Healthcare focuses on Market-driven Research and not just on Molecule-driven Research. Thus Waksman Healthcare will be focused in innovative differentiations and platform technologies that can probably be applied across various therapeutic categories. As they say, small drops make big ocean; Waksman Healthcare will be glad to celebrate success with every small innovation and every small commercialization. Of course, we do Dream Big, but we never forget every small step that we take. Our increased focus is on designing novel and patentable technologies or delivery systems. There has been a paradigm shift in drug delivery technologies from conventional dosage forms to controlled release and sophisticated delivery systems, based on the concepts of biopharmaceutics and pharmacokinetic driven by pharmacodynamic activity and therapeutic needs. The future drug research must be based on current therapeutic needs of the target markets and provide solutions to the therapy and market gaps, than only looking at target molecular structure.

Technology Expertise

API: Chiral Chemistry and NCEs
CDS with Microspheres
Formulation: Mucoadhesive Microspheres and Floatation
In-Situ Gel Technology for Injectable SR & Ophathalmic Drugs
Microencapsulation technology
Nano-particles for enhancing Bioavailability
Osmotic Release Technology
Rapid Release Technology
Sequential Drug Delivery System
Transdermal Penetration Enhancers